SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. (QUBT) is facing significant downward pressure and intense community debate as investors react to its recent financial performance, high short interest, and ongoing concerns about dilution. While proponents highlight the company's room-temperature photonics technology and potential for future contracts, skeptics are actively targeting the stock, citing poor revenue growth relative to spending and a broader slump across the quantum sector.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is generating significant buzz as investors track potential pharmaceutical manufacturing contracts and speculation around onshoring drug production, coupled with optimism regarding their latest earnings performance. Community sentiment remains highly split, with bulls pointing to the company's industrial pivot and valuation as a long-term play, while others remain skeptical of the stock's tendency for hype-driven volatility.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as investors closely monitor the upcoming earnings report and anticipate news regarding potential high-volume production orders from major hyperscale customers. The community is actively debating the company's ability to capitalize on AI infrastructure expansion, with many focused on whether recent technological validations will finally transition into sustained, scalable revenue growth.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending as investors monitor the company's progress toward a high-stakes April 10 PDUFA date for its skin cancer drug. Community discussion is heavily split between optimism for an approval based on recent FDA resubmission progress and skepticism regarding the potential for another Complete Response Letter, with many traders closely watching options activity and institutional positioning as a binary catalyst approaches.

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Anika Therapeutics Inc.

Anika Therapeutics is under intense scrutiny as investors debate the impact of executive leadership changes and recent product updates on long-term growth. While some in the community see the recent stock buybacks and product pipeline as a potential catalyst for turnaround, others remain skeptical due to concerns over revenue execution and persistent profitability challenges.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is currently trending as investors weigh its critical role in AI infrastructure, particularly as a key supplier for high-speed optical transceivers and datacom packaging. Community discussion centers on whether the stock's recent valuation and manufacturing growth can maintain momentum following its latest financial results, with many traders actively debating the merits of tactical entries during periods of high volatility.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

MATH is seeing heightened interest as investors speculate on potential breakout momentum, with discussions heavily focused on historical pump-and-dump patterns and its status as a low-cap asset. While some community members remain optimistic about significant upside targets linked to broader market rotations, others are expressing frustration over stagnant performance and questioning the leadership.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is under heavy scrutiny following an 8-K filing regarding a $100 million loan agreement, where the company alleges that its collateral of Datavault AI shares was illegally sold without authorization, triggering a lawsuit against the lender and Bank of New York Mellon. While some community members view the legal action as a potential catalyst for recovering assets and exposing market manipulation, others remain deeply skeptical, citing the company's history of financial delays, dilution, and the CEO's controversial track record.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is capturing significant market attention as investors weigh a strong quarterly earnings beat and strategic acquisitions against a volatile landscape of sector-wide dilution risks and institutional hedging. Community discussions are heavily focused on the company's long-term commercialization roadmap, its role in defense-related quantum security, and whether its recent performance justifies the premium valuation compared to other pure-play quantum peers.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant community momentum as investors weigh the stock's long-term potential against volatility driven by macro-level geopolitical headlines and speculation surrounding a potential SpaceX IPO. Shareholders are actively debating the company's valuation, recent satellite manufacturing hiring, and the strategic importance of its commercial partnerships during a period of market-wide turbulence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Can Fin Homes - Strong on Profitability, Weak on Growth and more

In this briefing: Can Fin Homes - Strong on Profitability, Weak on Growth Primer: Royal Orchid Hotels (ROHL IN) - Oct 2025 Can Fin Homes Limited - Consolidation Phase Ending; Growth Outlook Turning Constructive! Primer: Chemcon Speciality Chemicals (CHEMCON IN) - Oct 2025 Federal Bank Q2 FY26: Strong Operational Beat, RoA Strategy On Track - But Is the Re-Rating Done 1. Can Fin Homes - Strong on Profitability, Weak on Growth Can Fin Homes’ (CANF) Q2FY26 earnings were ahead of our estimates, largely due to higher-than-expected NIMs (4%) and muted credit costs (3bps) NIMs reflated sharply, driven by lower cost of funds (-30bps QoQ) due to re-pricing of bank borrowings, while transmission on the asset side remained limited (25bps during FY26) However, AUM/disbursements growth remained tepid (+8.4%/+6.9% YoY) amidst moderation in overall housing demand and protracted issues in Karnataka and Telangana Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief India: Can Fin Homes Limited - Consolidation Phase Ending; Growth Outlook Turning Constructive! and more

In this briefing: Can Fin Homes Limited - Consolidation Phase Ending; Growth Outlook Turning Constructive! Primer: Chemcon Speciality Chemicals (CHEMCON IN) - Oct 2025 Federal Bank Q2 FY26: Strong Operational Beat, RoA Strategy On Track - But Is the Re-Rating Done Lenskart Solutions Pre-IPO - The Negatives - International Ops Largely Acquisition Driven Molbio Diagnostics Limited Pre-IPO: Steady Growths in Topline And Profitability 1. Can Fin Homes Limited - Consolidation Phase Ending; Growth Outlook Turning Constructive! Key States Showing Signs of Recovery: CANF’s key states – Karnataka (KA, owing to eKhata issue) and Telangana (TL) have reported muted growth. However, the company is seeing signs of revival, particularly in KA. The management has indicated that the KA government has announced certain measures regarding eKhata, which are directionally positive and should support growth revival in the state. Thus, the management expects the monthly disbursement run-rate in KA to improve from Q3 onwards and scale up to a Rs 300 Cr/month disbursement run-rate in Q4 vs the current monthly run-rate of Rs 260 Cr.

Chemcon Speciality Chemicals Ltd. engages in the manufacture and sale of chemicals for pharmaceuticals and oilfield industries. Its products include oilfield chemicals, pharmaceutical chemicals, silanes, and agro chemicals intermediate. The company was founded on December 15, 1988 and is headquartered in Vadodara, India.

CHEMCON.NSE
Chemcon Speciality Chemicals Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest CHEMCON.NSE News

CHEMCON.NSEChemcon Speciality Chemicals Ltd.